Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment
Traci C. Green, Jeffrey Bratberg, Deborah S. Finnell
We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.
Fingerprint Dive into the research topics of 'Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment'. Together they form a unique fingerprint.
Pandemics Medicine & Life Sciences
Opioid Analgesics Medicine & Life Sciences
Formal Social Control Medicine & Life Sciences
Pharmacists Medicine & Life Sciences
Green, T. C., Bratberg, J., & Finnell, D. S. (2020). Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment. Substance Abuse, 41(2), 147-149. https://doi.org/10.1080/08897077.2020.1752351
Opioid use disorder and the COVID 19 pandemic : A call to sustain regulatory easements and further expand access to treatment. / Green, Traci C.; Bratberg, Jeffrey; Finnell, Deborah S.
In: Substance Abuse, Vol. 41, No. 2, 02.04.2020, p. 147-149.
Green, TC, Bratberg, J & Finnell, DS 2020, 'Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment', Substance Abuse, vol. 41, no. 2, pp. 147-149. https://doi.org/10.1080/08897077.2020.1752351
Green TC, Bratberg J, Finnell DS. Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment. Substance Abuse. 2020 Apr 2;41(2):147-149. https://doi.org/10.1080/08897077.2020.1752351
Green, Traci C. ; Bratberg, Jeffrey ; Finnell, Deborah S. / Opioid use disorder and the COVID 19 pandemic : A call to sustain regulatory easements and further expand access to treatment. In: Substance Abuse. 2020 ; Vol. 41, No. 2. pp. 147-149.
@article{3c73cbd51c2f4560bdca92690e9eb367,
title = "Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment",
abstract = "We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.",
keywords = "Pandemic, buprenorphine, methadone, opioid use disorder, pharmacists, policy, regulations",
author = "Green, {Traci C.} and Jeffrey Bratberg and Finnell, {Deborah S.}",
note = "Publisher Copyright: {\textcopyright} 2020, {\textcopyright} 2020 Taylor & Francis Group, LLC. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
journal = "Substance Abuse",
T1 - Opioid use disorder and the COVID 19 pandemic
T2 - A call to sustain regulatory easements and further expand access to treatment
AU - Green, Traci C.
AU - Bratberg, Jeffrey
AU - Finnell, Deborah S.
N1 - Publisher Copyright: © 2020, © 2020 Taylor & Francis Group, LLC. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
N2 - We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.
AB - We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.
KW - Pandemic
KW - buprenorphine
KW - methadone
KW - opioid use disorder
KW - pharmacists
KW - regulations
JO - Substance Abuse
JF - Substance Abuse